List of Tables
Table 1. Global Tumor Targeting Peptides Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Tumor Targeting Peptides Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Tumor Targeting Peptides Market Competitive Situation by Manufacturers in 2025
Table 4. Global Tumor Targeting Peptides Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Tumor Targeting Peptides Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Tumor Targeting Peptides Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Tumor Targeting Peptides Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Tumor Targeting Peptides Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Tumor Targeting Peptides, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Tumor Targeting Peptides, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Tumor Targeting Peptides, Product Types and Applications
Table 12. Global Key Manufacturers of Tumor Targeting Peptides, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tumor Targeting Peptides Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tumor Targeting Peptides Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tumor Targeting Peptides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Tumor Targeting Peptides Sales by Region (kg), 2021–2026
Table 18. Global Tumor Targeting Peptides Sales Market Share by Region (2021–2026)
Table 19. Global Tumor Targeting Peptides Sales by Region (kg), 2027–2032
Table 20. Global Tumor Targeting Peptides Sales Market Share by Region (2027–2032)
Table 21. Global Tumor Targeting Peptides Revenue by Region (US$ Million), 2021–2026
Table 22. Global Tumor Targeting Peptides Revenue Market Share by Region (2021–2026)
Table 23. Global Tumor Targeting Peptides Revenue by Region (US$ Million), 2027–2032
Table 24. Global Tumor Targeting Peptides Revenue Market Share by Region (2027–2032)
Table 25. North America Tumor Targeting Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Tumor Targeting Peptides Sales by Country (kg), 2021–2026
Table 27. North America Tumor Targeting Peptides Sales by Country (kg), 2027–2032
Table 28. North America Tumor Targeting Peptides Revenue by Country (US$ Million), 2021–2026
Table 29. North America Tumor Targeting Peptides Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Tumor Targeting Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Tumor Targeting Peptides Sales by Country (kg), 2021–2026
Table 32. Europe Tumor Targeting Peptides Sales by Country (kg), 2027–2032
Table 33. Europe Tumor Targeting Peptides Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Tumor Targeting Peptides Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Tumor Targeting Peptides Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Tumor Targeting Peptides Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Tumor Targeting Peptides Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Tumor Targeting Peptides Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Tumor Targeting Peptides Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Tumor Targeting Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Tumor Targeting Peptides Sales by Country (kg), 2021–2026
Table 42. Latin America Tumor Targeting Peptides Sales by Country (kg), 2027–2032
Table 43. Latin America Tumor Targeting Peptides Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Tumor Targeting Peptides Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Tumor Targeting Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Tumor Targeting Peptides Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Tumor Targeting Peptides Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Tumor Targeting Peptides Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Tumor Targeting Peptides Revenue by Country (US$ Million), 2027–2032
Table 50. Global Tumor Targeting Peptides Sales (kg) by Type (2021–2026)
Table 51. Global Tumor Targeting Peptides Sales (kg) by Type (2027–2032)
Table 52. Global Tumor Targeting Peptides Sales Market Share by Type (2021–2026)
Table 53. Global Tumor Targeting Peptides Sales Market Share by Type (2027–2032)
Table 54. Global Tumor Targeting Peptides Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Tumor Targeting Peptides Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Tumor Targeting Peptides Revenue Market Share by Type (2021–2026)
Table 57. Global Tumor Targeting Peptides Revenue Market Share by Type (2027–2032)
Table 58. Global Tumor Targeting Peptides Price (US$/g) by Type (2021–2026)
Table 59. Global Tumor Targeting Peptides Price (US$/g) by Type (2027–2032)
Table 60. Global Tumor Targeting Peptides Sales (kg) by Application (2021–2026)
Table 61. Global Tumor Targeting Peptides Sales (kg) by Application (2027–2032)
Table 62. Global Tumor Targeting Peptides Sales Market Share by Application (2021–2026)
Table 63. Global Tumor Targeting Peptides Sales Market Share by Application (2027–2032)
Table 64. Global Tumor Targeting Peptides Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Tumor Targeting Peptides Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Tumor Targeting Peptides Revenue Market Share by Application (2021–2026)
Table 67. Global Tumor Targeting Peptides Revenue Market Share by Application (2027–2032)
Table 68. Global Tumor Targeting Peptides Price (US$/g) by Application (2021–2026)
Table 69. Global Tumor Targeting Peptides Price (US$/g) by Application (2027–2032)
Table 70. Cayman Chemical Company Information
Table 71. Cayman Chemical Description and Business Overview
Table 72. Cayman Chemical Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. Cayman Chemical Tumor Targeting Peptides Product
Table 74. Cayman Chemical Recent Developments/Updates
Table 75. Danaher(Abcam) Company Information
Table 76. Danaher(Abcam) Description and Business Overview
Table 77. Danaher(Abcam) Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Danaher(Abcam) Tumor Targeting Peptides Product
Table 79. Danaher(Abcam) Recent Developments/Updates
Table 80. Selleck Chemicals Company Information
Table 81. Selleck Chemicals Description and Business Overview
Table 82. Selleck Chemicals Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Selleck Chemicals Tumor Targeting Peptides Product
Table 84. Selleck Chemicals Recent Developments/Updates
Table 85. Cell Guidance Systems Company Information
Table 86. Cell Guidance Systems Description and Business Overview
Table 87. Cell Guidance Systems Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. Cell Guidance Systems Tumor Targeting Peptides Product
Table 89. Cell Guidance Systems Recent Developments/Updates
Table 90. RayBiotech Company Information
Table 91. RayBiotech Description and Business Overview
Table 92. RayBiotech Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. RayBiotech Tumor Targeting Peptides Product
Table 94. RayBiotech Recent Developments/Updates
Table 95. Merck KGaA Company Information
Table 96. Merck KGaA Description and Business Overview
Table 97. Merck KGaA Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. Merck KGaA Tumor Targeting Peptides Product
Table 99. Merck KGaA Recent Developments/Updates
Table 100. PEPTIDE INSTITUTE Company Information
Table 101. PEPTIDE INSTITUTE Description and Business Overview
Table 102. PEPTIDE INSTITUTE Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. PEPTIDE INSTITUTE Tumor Targeting Peptides Product
Table 104. PEPTIDE INSTITUTE Recent Developments/Updates
Table 105. Bachem Company Information
Table 106. Bachem Description and Business Overview
Table 107. Bachem Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. Bachem Tumor Targeting Peptides Product
Table 109. Bachem Recent Developments/Updates
Table 110. ASIA BIOSCIENCE CO Company Information
Table 111. ASIA BIOSCIENCE CO Description and Business Overview
Table 112. ASIA BIOSCIENCE CO Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. ASIA BIOSCIENCE CO Tumor Targeting Peptides Product
Table 114. ASIA BIOSCIENCE CO Recent Developments/Updates
Table 115. Biorbyt Company Information
Table 116. Biorbyt Description and Business Overview
Table 117. Biorbyt Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 118. Biorbyt Tumor Targeting Peptides Product
Table 119. Biorbyt Recent Developments/Updates
Table 120. CPC Scientific Inc Company Information
Table 121. CPC Scientific Inc Description and Business Overview
Table 122. CPC Scientific Inc Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 123. CPC Scientific Inc Tumor Targeting Peptides Product
Table 124. CPC Scientific Inc Recent Developments/Updates
Table 125. Advanced ChemTech Company Information
Table 126. Advanced ChemTech Description and Business Overview
Table 127. Advanced ChemTech Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 128. Advanced ChemTech Tumor Targeting Peptides Product
Table 129. Advanced ChemTech Recent Developments/Updates
Table 130. TargetMol Chemicals Company Information
Table 131. TargetMol Chemicals Description and Business Overview
Table 132. TargetMol Chemicals Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 133. TargetMol Chemicals Tumor Targeting Peptides Product
Table 134. TargetMol Chemicals Recent Developments/Updates
Table 135. QYAOBIO Company Information
Table 136. QYAOBIO Description and Business Overview
Table 137. QYAOBIO Tumor Targeting Peptides Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 138. QYAOBIO Tumor Targeting Peptides Product
Table 139. QYAOBIO Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Tumor Targeting Peptides Distributors List
Table 143. Tumor Targeting Peptides Customers List
Table 144. Tumor Targeting Peptides Market Trends
Table 145. Tumor Targeting Peptides Market Drivers
Table 146. Tumor Targeting Peptides Market Challenges
Table 147. Tumor Targeting Peptides Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tumor Targeting Peptides
Figure 2. Global Tumor Targeting Peptides Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Tumor Targeting Peptides Market Share by Type: 2025 & 2032
Figure 4. Therapeutic Targeting Peptides Product Picture
Figure 5. Imaging Targeting Peptides Product Picture
Figure 6. Global Tumor Targeting Peptides Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Tumor Targeting Peptides Market Share by Application: 2025 & 2032
Figure 8. Scientific Research
Figure 9. Pharmaceuticals
Figure 10. Global Tumor Targeting Peptides Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Tumor Targeting Peptides Market Size (US$ Million), 2021–2032
Figure 12. Global Tumor Targeting Peptides Sales (kg), 2021–2032
Figure 13. Global Tumor Targeting Peptides Average Price (US$/g), 2021–2032
Figure 14. Tumor Targeting Peptides Report Years Considered
Figure 15. Tumor Targeting Peptides Sales Share by Manufacturers in 2025
Figure 16. Global Tumor Targeting Peptides Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Tumor Targeting Peptides Players: Market Share by Revenue in Tumor Targeting Peptides in 2025
Figure 18. Tumor Targeting Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Tumor Targeting Peptides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Tumor Targeting Peptides Sales Market Share by Country (2021–2032)
Figure 21. North America Tumor Targeting Peptides Revenue Market Share by Country (2021–2032)
Figure 22. United States Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Tumor Targeting Peptides Sales Market Share by Country (2021–2032)
Figure 25. Europe Tumor Targeting Peptides Revenue Market Share by Country (2021–2032)
Figure 26. Germany Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Tumor Targeting Peptides Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Tumor Targeting Peptides Revenue Market Share by Region (2021–2032)
Figure 33. China Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Tumor Targeting Peptides Sales Market Share by Country (2021–2032)
Figure 41. Latin America Tumor Targeting Peptides Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Tumor Targeting Peptides Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Tumor Targeting Peptides Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Tumor Targeting Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Tumor Targeting Peptides by Type (2021–2032)
Figure 52. Global Revenue Market Share of Tumor Targeting Peptides by Type (2021–2032)
Figure 53. Global Tumor Targeting Peptides Price (US$/g) by Type (2021–2032)
Figure 54. Global Sales Market Share of Tumor Targeting Peptides by Application (2021–2032)
Figure 55. Global Revenue Market Share of Tumor Targeting Peptides by Application (2021–2032)
Figure 56. Global Tumor Targeting Peptides Price (US$/g) by Application (2021–2032)
Figure 57. Tumor Targeting Peptides Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
